Document Detail

Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants.
MedLine Citation:
PMID:  20659937     Owner:  NLM     Status:  In-Data-Review    
Background Invasive fungal infections are a major cause of morbidity and mortality in preterm infants. The authors conducted the first prospective, randomised controlled trial of nystatin compared with fluconazole for the prevention of fungal colonisation and invasive fungal infection in very low birth weight (VLBW) neonates. Methods During a 12-month period, all VLBW neonates were assigned randomly to receive nystatin (1 ml suspension, 100 000 U/ml, every 8 h), fluconazole (3 mg/kg body weight, every third day) or placebo from birth until day 30 of life (day 45 for neonates weighing <1000 g at birth). The authors performed weekly surveillance cultures and systemic fungal susceptibility testing. Results During the study period, 278 infants (fluconazole group, n=93; nystatin group, n=94; control group, n=91) weighing <1500 g at birth were admitted. There were no differences in birth weight, gestation, gender or risk factors for fungal infection among the groups. Fungal colonisation occurred in 11.7% of the nystatin group and 10.8% of the fluconazole group, as compared with 42.9% of the control group. The incidence of invasive fungal infection was 4.3% in the nystatin group and 3.2% in the fluconazole group, as compared with 16.5% in the control group. There were no differences in fungal colonisation and invasive fungal infection between the nystatin and fluconazole groups. Conclusions Prophylactic nystatin and fluconazole reduce the incidence of colonisation and invasive fungal infection in VLBW neonates. The authors believe that nystatin is an alternative to fluconazole, because nystatin is safe, inexpensive, well tolerated and effective.
Cumhur Aydemir; Serife Suna Oguz; Evrim Alyamac Dizdar; Melek Akar; Yusuf Unal Sarikabadayi; Sibel Saygan; Omer Erdeve; Ugur Dilmen
Related Documents :
22675157 - The effect of prenatal highly active antiretroviral therapy (haart) on the transmission...
25480837 - Management of preterm giant sacrococcygeal teratoma (gsct) with an excellent outcome.
17252087 - Pertussis in australia today - a disease of adolescents and adults that can kill infants.
7818637 - Neonatal serologic screening and early treatment for congenital toxoplasma gondii infec...
8916367 - Maternal alcohol use and risk of orofacial cleft birth defects.
24013477 - Preventing inhospital newborn falls: a literature review.
Publication Detail:
Type:  Journal Article     Date:  2010-07-21
Journal Detail:
Title:  Archives of disease in childhood. Fetal and neonatal edition     Volume:  96     ISSN:  1468-2052     ISO Abbreviation:  Arch. Dis. Child. Fetal Neonatal Ed.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9501297     Medline TA:  Arch Dis Child Fetal Neonatal Ed     Country:  England    
Other Details:
Languages:  eng     Pagination:  F164-8     Citation Subset:  AIM; IM    
Neonatal Intensive Care Unit, Zekai Tahir Burak Maternity Hospital, 06100, Samanpazari, Ankara, Turkey;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  First skull of Antillothrix bernensis, an extinct relict monkey from the Dominican Republic.
Next Document:  Do differences in delivery room intubation explain different rates of bronchopulmonary dysplasia bet...